[Apropos of a case of Gayet-Wernicke's encephalopathy in a latent epileptic. Centrophenoxine and thiamine. Electro-clinical contraindications].
D000085:Acetates / Q000009:adverse effects; D000328:Adult; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D004830:Epilepsy, Tonic-Clonic / Q000209:etiology*; D006801:Humans; D006879:Hydroxocobalamin / Q000627:therapeutic use; D007275:Injections, Intravenous; D007538:Isoniazid / Q000009:adverse effects; D008297:Male; D002504:Meclofenoxate / Q000627:therapeutic use; D010634:Phenobarbital / Q000627:therapeutic use; D011736:Pyridoxine / Q000627:therapeutic use; D013375:Substance Withdrawal Syndrome; D013831:Thiamine / Q000627:therapeutic use*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy; D014804:Vitamin B Deficiency / Q000188:drug therapy* / Q000209:etiology; D014899:Wernicke Encephalopathy / Q000188:drug therapy
D000085:Acetates; D000697:Central Nervous System Stimulants; D002504:Meclofenoxate; D011736:Pyridoxine; D006879:Hydroxocobalamin; D007538:Isoniazid; D013831:Thiamine; D010634:Phenobarbital
A propos d'un cas d'encéphalopathie de Gayet-Wernicke chez un épileptique latent. Centrophénoxine et Thiamine. Contradictions électro-cliniques.